How many studies have been conducted on Intercellular Adhesion Molecule 3?

BiohacksAI has indexed 300 PubMed studies on Intercellular Adhesion Molecule 3, including 3 randomized controlled trials (RCTs). 20% of studies involve human subjects.

What are the main research areas for Intercellular Adhesion Molecule 3?

The primary research domains for Intercellular Adhesion Molecule 3 are 🛡️ Immunity, 🔬 Inflammation, 🔬 Oncology. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Intercellular Adhesion Molecule 3

A membrane glycoprotein and cell adhesion molecule expressed by LEUKOCYTES that contains multiple Ig-like domains. It is a ligand for LFA-1 (integrin alphaLbeta2) and integrin alpha-D/beta-2. Its interaction with LFA-1 may play a role in the PHAGOCYTOSIS of NEUTROPHILS by MACROPHAGES following APOPTOSIS.

300+ PubMed studies analyzed · 3 RCTs · Evidence Score: 47.7

Research Domains

Intercellular Adhesion Molecule 3 has been studied across 16 research domains including 🛡️ Immunity, 🔬 Inflammation, 🔬 Oncology, 🫁 Liver & Detox, 🧠 Cognitive. The primary research focus is 🛡️ Immunity with 21% of studies addressing this area.

Loading evidence profile...

This evidence profile for Intercellular Adhesion Molecule 3 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.